skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8128

Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study

(2139) Views  (462) Full article downloads

Authors: Davide Uccellini, G Grampa, I La Spina, D Nasuelli, I Neromante, L Politini, F Reverberi, D Porazzi, V Carli, G Camardese

Published Date February 2006 Volume 2006:2(1) Pages 95 - 100
DOI: http://dx.doi.org/10.2147/NDT.S

Davide Uccellini1, G Grampa1, I La Spina1, D Nasuelli1, I Neromante1, L Politini1, F Reverberi1, D Porazzi1, V Carli2, G Camardese2

1UO di Neurologia, AO “Ospedale di Circolo di Busto A”, Busto Arsizio Varese, Italy; 2Istituto di Psichiatria e Psicologia dell’Università Cattolica del Sacro Cuore, Roma, Italy

Introduction: Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population.

Keywords: essential tremor, postural tremor, action tremor, mirtazapine, treatment, transcranial magnetic stimulation